910 filings
Page 17 of 46
8-K
ARMP
Armata Pharmaceuticals, Inc.
11 Sep 17
Departure of Directors or Certain Officers
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
11 Sep 17
AmpliPhi Biosciences / JEREMY CURNOCK COOK ownership change
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
11 Sep 17
AmpliPhi Biosciences / PAUL C GRINT ownership change
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
11 Sep 17
AmpliPhi Biosciences / Steven Robert Martin ownership change
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
11 Sep 17
AmpliPhi Biosciences / LOUIS DRAPEAU ownership change
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
11 Sep 17
AmpliPhi Biosciences / Wendy S. Johnson ownership change
12:00am
10-Q
2017 Q2
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
14 Aug 17
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
14 Aug 17
AmpliPhi Biosciences Reports Second Quarter 2017 Financial Results
12:00am
DEF 14A
ARMP
Armata Pharmaceuticals, Inc.
Definitive proxy
24 Jul 17
12:00am
PRE 14A
ARMP
Armata Pharmaceuticals, Inc.
Preliminary proxy
14 Jul 17
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
30 Jun 17
First Amendment to Common Stock Issuance Agreement
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
6 Jun 17
Regulation FD Disclosure
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
5 Jun 17
Departure of Directors or Certain Officers
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
1 Jun 17
AmpliPhi Biosciences / IGOR BILINSKY ownership change
12:00am
10-Q
2017 Q1
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
15 May 17
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
15 May 17
AmpliPhi Biosciences Reports First Quarter 2017 Financial Results
12:00am
8-K/A
ARMP
Armata Pharmaceuticals, Inc.
10 May 17
Other Events
12:00am
424B4
ARMP
Armata Pharmaceuticals, Inc.
8 May 17
Prospectus supplement with pricing info
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
8 May 17
AmpliPhi Biosciences Announces Pricing of $10.4 Million Underwritten Public Offering of
12:00am
EFFECT
ARMP
Armata Pharmaceuticals, Inc.
4 May 17
Notice of effectiveness
12:00am